Estimating the Cost of Pulmonary Embolism in Greece with the help of large data

Introduction: The cost of treatment of pulmonary embolism for Greece has been studied from the data of the Pulmonary Embolism Practice of the Larissa University General Hospital (LUGH) and the National Institute of Health Services (NIHS). Purpose: To estimate the cost of Pulmonary Embolism which Greece is charged in monetary units per year. Methodology: Taking into account the treatment modalities of the randomized patients of the LUGH Pulmonary Embolism Practice, the cost of the NIHS was calculated from 101,426 electronic prescriptions for Pulmonary Disease and the cost of the Pulmonary Disease was estimated for the years 2013 - 2017. Results: The study of clinic patients showed that in 2013 the total charge for the treatment of Pulmonary Embolism was 312.382,61 € while in 2017 it was 1.369.118, 23 €. Newer oral anticoagulants (DOACs) account for 92.69% of online prescriptions and adjusting the rate to 101,426 electronic prescriptions it is estimated that 94,410 electronic prescriptions are charged by the state with € 4,046,086.79 while 2,474 electronic prescriptions which are therapeutic methods with Low Molecular Heparines cost 103,692.75€. The total burden for Greece for the years 2013 - 2017 for Pulmonary Embolism is € 4,149,779.54. Conclusions: The cost of medication has a significant impact on health costs and the increase in burden per year confirms the best diagnostic tools for the treatment of Pulmonary Embolism.